COVID-19 pandemic
China approves BBIBP-CorV made by Sinopharm for general use, after the vaccine was considered to be 79.34% effective.
Sources: CNN
Changes
- China approves the country's first homegrown vaccine made by Sinopharm. It comes after the vaccine is 79.34% effective.
- China approves the country's first homegrown vaccine, made by Sinopharm. It comes after the vaccine is deemed to be 79.34% effective.
- China approves BBIBP-CorV made by Sinopharm for general use, after the vaccine was considered to be 79.34% effective.